Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05480956 · ClinicalTrials.gov registry record · NA
SIRI Checklist: An Integrated Hospital Model to Optimize HIV Prevention in Persons Who Inject Drugs
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT05480956 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 60 participants.
The verdict
NCT05480956, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to develop and test a serious injection-related injections (SIRI) checklist aimed at increasing evidence-based treatment for rural people who use drugs (PWUD) including innovative, long-acting injectable agents. The central hypothesis is that hospital-based care models can successfully engage rural and Southern (PWUD) in effective addiction treatment and infection prevention. The activities in this study will be foundational to Ending the HIV epidemic in rural states.
Interventions
- BEHAVIORAL SIRI Checklist
- BEHAVIORAL Enhanced Peer Recovery Coach
- BEHAVIORAL SIRI Checklist + Enhanced Peer Recovery Coach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-10-11 |
| Est. Completion | 2025-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05480956
The ClinicalTrials.gov registry entry for NCT05480956 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which SIRI Checklist is the first listed.
NCT05480956 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05480956 about?
NCT05480956 is a clinical study titled "SIRI Checklist: An Integrated Hospital Model to Optimize HIV Prevention in Persons Who Inject Drugs". The purpose of this study is to develop and test a serious injection-related injections (SIRI) checklist aimed at increasing evidence-based treatment for rural people who use drugs (PWUD) including innovative, long-acting injectable agents. The central hypothesis is that hospital-based care models c...
What is the current status of trial NCT05480956?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2022-10-11. Estimated completion is 2025-07-01.
What interventions are being tested in trial NCT05480956?
The interventions under investigation include: SIRI Checklist (BEHAVIORAL), Enhanced Peer Recovery Coach (BEHAVIORAL), SIRI Checklist + Enhanced Peer Recovery Coach (BEHAVIORAL).
Who is sponsoring clinical trial NCT05480956?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.